Los Angeles Capital Management
VIVO

Los Angeles Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Los Angeles Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,034
Closed -$488K – 1424
2022
Q2 		$488K Sell
16,034
-35,497
-69% -$960K ﹤0.01% 972
2022
Q1 		$1.34M Sell
51,531
-6,740
-12% -$160K 0.01% 658
2021
Q4 		$1.19M Sell
58,271
-39,790
-41% -$763K ﹤0.01% 667
2021
Q3 		$1.89M Sell
98,061
-4,939
-5% -$98.5K 0.01% 542
2021
Q2 		$2.29M Buy
103,000
+51,026
+98% +$1.08M 0.01% 558
2021
Q1 		$1.36M Buy
51,974
+7,759
+18% +$184K 0.01% 760
2020
Q4 		$826K Sell
44,215
-2,840
-6% -$53K ﹤0.01% 1017
2020
Q3 		$799K Sell
47,055
-47,141
-50% -$916K ﹤0.01% 907
2020
Q2 		$2.19M Buy
94,196
+20,077
+27% +$291K 0.01% 595
2020
Q1 		$623K Buy
+74,119
New +$624K ﹤0.01% 839
2019
Q2 		– Sell
-87,715
Closed -$1.54M – 1460
2019
Q1 		$1.54M Sell
87,715
-104,990
-54% -$1.75M 0.01% 728
2018
Q4 		$3.35M Buy
192,705
+72,036
+60% +$1.23M 0.02% 436
2018
Q3 		$1.8M Buy
120,669
+36,952
+44% +$573K 0.01% 695
2018
Q2 		$1.33M Hold
83,717
– – 0.01% 814
2018
Q1 		$1.19M Sell
83,717
-50,995
-38% -$755K 0.01% 778
2017
Q4 		$1.89M Buy
134,712
+47,311
+54% +$693K 0.01% 683
2017
Q3 		$1.25M Buy
87,401
+31,140
+55% +$445K 0.01% 748
2017
Q2 		$886K Sell
56,261
-6,440
-10% -$92.8K 0.01% 788
2017
Q1 		$865K Buy
62,701
+8,831
+16% +$123K 0.01% 760
2016
Q4 		$953K Hold
53,870
– – 0.01% 716
2016
Q3 		$1.04M Buy
53,870
+6,810
+14% +$133K 0.01% 709
2016
Q2 		$918K Buy
+47,060
New +$923K 0.01% 727

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Los Angeles Capital Management's VIVO Position: Q3 2022 in Review

Los Angeles Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2022, closing a stake of 16,034 shares — an estimated $488K sold.

Los Angeles Capital Management first reported a position in VIVO in Q2 2016 and held it in 22 quarters. The position peaked at $3.35M in Q4 2018. 203 funds tracked by Wall St. Rank hold VIVO as of Q3 2022.

  • Los Angeles Capital Management reported no remaining Meridian Bioscience Inc position as of Q3 2022 after selling out during the quarter.
  • Los Angeles Capital Management sold 16,034 Meridian Bioscience Inc shares in Q3 2022, an estimated $488K.
  • Los Angeles Capital Management first reported a position in Meridian Bioscience Inc in Q2 2016 and held it in 22 quarters.
  • Los Angeles Capital Management's Meridian Bioscience Inc position peaked at $3.35M in Q4 2018.
  • 203 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2022.

Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.